AstraZeneca to buy China’s Gracell Bio for up to $1.2 billion
London: AstraZeneca said on Tuesday it will buy Gracell Biotechnologies for up to $1.2 billion as the Anglo-Swedish pharma company furthers its cell therapy ambitions and boosts its presence in …